Appearance and Shape (20°C) | Solid |
---|---|
CAS RN | 231277-92-2 |
MDL number | MFCD09264194 |
Molecular weight | 581.06 |
Molecular Formula | C29H26ClFN4O4S |
Product code | ICTL0360 |
Purity/Analytical Methods | >98.0%(T)(HPLC) |
Reaxys-RN | 10502247 |
Situations to avoid | Air Sensitive,Heat Sensitive |
Store under inert gas | Store under inert gas |
Appearance | White to Light yellow powder to crystal |
---|
Hazard statement | H362 : May cause harm to breast-fed children H413 : May cause long lasting harmful effects to aquatic life. |
---|---|
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P263 : Avoid contact during pregnancy/ while nursing P273 : Avoid release to the environment P260 : Do not breathe dusts or mists P270 : Do not eat, drink or smoke when using this product P201 : Obtain special instructions before use P264 : Wash skin thoroughly after handling P308 + P313 : IF exposed or concerned: Get medical advice/ attention. |
RTECS# | VA0952500 |
---|
Chemicals by Class 6-Membered Heterocyclic Compounds [Chemical Structural Class] Pyrimidines [Chemical Structural Class] Quinazolines [Chemical Structural Class]
Life Science Biochemicals and Reagents Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Ingredients (for Research and Experimental Use) Antitumor Molecular Target Inhibitors Cell Biology Cancer Research Antitumor Agents Receptor Tyrosine Kinase (RTK) Inhibitors Tyrosine Kinase Inhibitors [Antitumor Agents] Cell Signaling and Neuroscience Kinase/Phosphatase Biology Receptor Tyrosine Kinase (RTK) Inhibitors Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Ingredients (for Research and Experimental Use) Antitumor Molecular Target Inhibitors